Elhízás: vizsgálatok itt: Kína
247 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaMazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 700
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07897305 - No phaseNot yet taking people in KínaiWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 216
- Run by
- Liu Yan
See details and how to joinNCT07237750 - No phaseNot yet taking people in KínaIndividual Variability in Energy Compensation After a 12-Week Supervised Exercise Intervention
- Where
- Shenzhen
- Életkor
- 18 év to 40 év
- People
- 150
- Run by
- Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
See details and how to joinNCT07893249 - No phaseNot yet taking people in KínaChinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
- Where
- Taiyuan
- Életkor
- 18 év to 79 év
- People
- 25 974
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07884903 - 1. fázisTaking peopleA Study of IBI3046 in Participants With Overweight or Obesity
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 128
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07809945 - 1. fázisTaking peopleA Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
- Where
- Beijing, Guangzhou, Hangzhou, Jinan, Luzhou, Shanghai, Wuhan, Xianning, Zhengzhou
- Életkor
- 18 év to 65 év
- People
- 80
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07798284 - 2. fázisTaking peopleA Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes
- Where
- Beijing
- Életkor
- 18 év to 55 év
- People
- 200
- Run by
- BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07658560 - No phaseNot yet taking people in KínaYeast Protein Supplementation and Muscle Preservation During GLP-1RA-Induced Weight Loss
- Where
- Shenzhen
- Életkor
- 25 év to 50 év
- People
- 200
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07817823 - No phaseNot yet taking people in KínaEffects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
- Where
- Nanjing
- Életkor
- 18 év to 65 év
- People
- 80
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07847515 - No phaseNot yet taking people in KínaDe Novo Gastroesophageal Reflux Disease After Sleeve Gastrectomy With and Without Omentopexy
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 140
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT07854613 - 4. fázisTaking peopleEffect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 116
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07657676 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian, Huzhou, Jinan, Jinzhou, Kunming, Lanzhou, Linhai, Liuzhou, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Panjin, Pingxiang, Qingdao, Shanghai, Shenyang, Shenzhen, Siping, Suining, Suzhou, Ürümqi, Wanzhou, Wenzhou, Wuhan, Wuxi, Xiangyang, Xuancheng, Yibin, Yichang, Zhengzhou, Zhenjiang, Zunyi
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleA Study of BGM0504 in Early T2DM With Obesity
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 372
- Run by
- BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07743983 - 3. fázisNot yet taking people in KínaA Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
- Where
- Chengdu, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai
- Életkor
- 18 év and over
- People
- 192
- Run by
- Eli Lilly and Company
See details and how to joinNCT07790861 - No phaseTaking peopleEfficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity
- Where
- Guangzhou
- Életkor
- 18 év to 60 év
- People
- 200
- Run by
- Moon (Guangzhou) Biotechnology Co., Ltd.
See details and how to joinNCT07331974 - 3. fázisTaking peopleAMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Beijing, Guangzhou, Luoyang, Nanjing, Shenzhen, Tianjin
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571109 · EU 2024-520443-16-00 - 3. fázisNot yet taking people in KínaA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Beijing, Changchun, Changsha, Changzhou, Chongqing, Guangzhou, Jinan, Jining, Luoyang, Nanjing, Shenyang, Shijiazhuang, Suzhou, Tianjin, Xi'an, Zhenjiang
- Életkor
- 45 év to 64 év
- People
- 8500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - 3. fázisTaking peopleA Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Where
- Beijing, Changchun, Chengdu, Jinan, Shanghai, Wuhan, Zhengzhou
- Életkor
- 8 év to 18 év
- People
- 460 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00 - 1. fázisTaking peopleA Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants
- Where
- Beijing
- Életkor
- 18 év to 55 év
- People
- 126
- Run by
- Gan & Lee Pharmaceuticals.
See details and how to joinNCT07784699 - No phaseNot yet taking people in KínaEffect of Different-Flow High-Flow Nasal Cannula Versus Traditional Face Mask Oxygenation on Safe Apnea Time in Obese Patients
- Where
- Lianyungang
- Életkor
- 18 év to 65 év
- People
- 147
- Run by
- The First People's Hospital of Lianyungang
See details and how to joinNCT07843810 - 1. fázisNot yet taking people in KínaA Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses
- Where
- Jinan
- Életkor
- 18 év to 55 év
- People
- 122
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07841860 - 3. fázisTaking peoplePhase III Study of HRS-7535 for Hypertension With Overweight or Obesity
- Where
- Beijing, Harbin
- Életkor
- 18 év to 70 év
- People
- 648
- Run by
- Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07528027 - 4. fázisTaking peoplePre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
- Where
- Beijing, Chengdu, Chongqing, Hefei
- Életkor
- 18 év to 60 év
- People
- 60
- Run by
- West China Hospital
See details and how to joinNCT07718126 - No phaseTaking peopleA Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases
- Where
- Zhangzhou
- Életkor
- 18 év and over
- People
- 320
- Run by
- Zhangzhou Municipal Hospital
See details and how to joinNCT07836088 - 3. fázisNot yet taking people in KínaA Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents
- Where
- Hangzhou
- Életkor
- 12 év to 17 év
- People
- 192
- Run by
- Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07836270